世界の経皮的冠動脈形成術用薬剤溶出性バルーンカテーテル市場:医療機器パイプライン分析2016

◆英語タイトル:Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0191EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの概要
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向:開発段階別分析
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向:セグメント別分析
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向:領域別分析
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向:規制Path別分析
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向:承認日(推定)別分析
・企業別経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの開発動向(パイプライン製品、進行中の治験)
・経皮的冠動脈形成術用薬剤溶出性バルーンカテーテルの最近動向
【レポートの概要】

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Medical Devices Pipeline Assessment, 2016″ provides an overview of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Overview 5
3 Products under Development 6
3.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products by Stage of Development 6
3.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products by Territory 7
3.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products by Regulatory Path 8
3.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products by Estimated Approval Date 9
3.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Ongoing Clinical Trials 10
4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products under Development by Companies 11
4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies – Pipeline Products by Stage of Development 11
4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters – Pipeline Products by Stage of Development 12
5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies and Product Overview 13
5.1 Acrostak (Schweiz) AG Company Overview 13
5.1.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Caliber Therapeutics Company Overview 15
5.2.1 Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Concept Medical Inc Company Overview 17
5.3.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 20
5.4.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Micell Technologies, Inc. Company Overview 21
5.5.1 Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 Sahajanand Medical Technologies Private Limited Company Overview 23
5.6.1 Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 SurModics, Inc. Company Overview 24
5.7.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 The Spectranetics Corporation Company Overview 26
5.8.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Vascular Nanotransfer Technologies Company Overview 28
5.9.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 28
6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters- Recent Developments 30
6.1 May 19, 2016: EuroPCR 2016: Pantera Lux Drug-Coated Balloon Proves Non-Inferior to Drug-Eluting Stent 30
6.2 Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon 30
6.3 Oct 15, 2015: ISAR-DESIRE 4 Is First Trial to Examine Role of Lesion Preparation before Drug-Coated Balloon Therapy in Restenosis 31
6.4 Aug 18, 2015: Elixir Medical Receives 2015 Innovator of the Year Award from EK-UNICO 32
6.5 Jun 25, 2015: The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix Drug Coated Balloon, showing superior efficacy compared to standard PTA 32
6.6 Jun 09, 2015: CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use 33
7 Appendix 34
7.1 Methodology 34
7.2 About GlobalData 36
7.3 Contact Us 37
7.4 Disclaimer 37

1.1 List of Tables
Table 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development 6
Table 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory 7
Table 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path 8
Table 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date 9
Table 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials 10
Table 6: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies - Pipeline Products by Stage of Development 11
Table 7: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development 12
Table 8: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: Genie Catheter - Product Status 13
Table 10: Genie Catheter - Product Description 14
Table 11: Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Drug Delivery Balloon Catheter - Product Status 15
Table 13: Drug Delivery Balloon Catheter - Product Description 15
Table 14: TADD Device - Product Status 16
Table 15: TADD Device - Product Description 16
Table 16: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Magic Touch - Product Status 17
Table 18: Magic Touch - Product Description 17
Table 19: Concept Medical Inc - Ongoing Clinical Trials Overview 18
Table 20: Magic Touch - Assessment of the Novel MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions 19
Table 21: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: PTCA Drug Eluting Balloon - Product Status 20
Table 23: PTCA Drug Eluting Balloon - Product Description 20
Table 24: Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: Drug-Coated Balloon - Product Status 21
Table 26: Drug-Coated Balloon - Product Description 22
Table 27: Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: Identity Balloon Catheter - Product Status 23
Table 29: Identity Balloon Catheter - Product Description 23
Table 30: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 31: SurVeil Drug Coated Balloon - Coronary - Product Status 24
Table 32: SurVeil Drug Coated Balloon - Coronary - Product Description 25
Table 33: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: AngioSculptX - Product Status 26
Table 35: AngioSculptX - Product Description 27
Table 36: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: Mitomycin-Based DCB - Coronary - Product Status 28
Table 38: Mitomycin-Based DCB - Coronary - Product Description 28
Table 39: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Status 29
Table 40: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Description 29
Table 41: Glossary 35

1.2 List of Figures
Figure 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development 6
Figure 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory 7
Figure 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path 8
Figure 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date 9
Figure 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials 10

【掲載企業】

Acrostak (Schweiz) AG
Caliber Therapeutics
Concept Medical Inc
Lifetech Scientific (Shenzhen) Co., Ltd.
Micell Technologies, Inc.
Sahajanand Medical Technologies Private Limited
SurModics, Inc.
The Spectranetics Corporation
Vascular Nanotransfer Technologies

★調査レポート[世界の経皮的冠動脈形成術用薬剤溶出性バルーンカテーテル市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の経皮的冠動脈形成術用薬剤溶出性バルーンカテーテル市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆